Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy

Autor:	Joan Albert Barberà, Josep Font, Ricard Cervera, JR Badia, F. J. Muñoz-Rodriguez, Miguel Ingelmo, C Miret
Rok vydání:	1997
Předmět:	Agonist Adult Lung Diseases medicine.medical_specialty medicine.drug_class Corticosteroid treatment macromolecular substances 030204 cardiovascular system & hematology Gastroenterology Pathogenesis 03 medical and health sciences Therapeutic approach 0302 clinical medicine Rheumatology Internal medicine Administration Inhalation medicine Humans Lupus Erythematosus Systemic In patient Albuterol 030203 arthritis & rheumatology Lupus erythematosus integumentary system Inhalation business.industry Follow up studies Adrenergic beta-Agonists medicine.disease Bronchodilator Agents Immunology Female Radiography Thoracic business Pulmonary Ventilation Tomography X-Ray Computed Follow-Up Studies
Zdroj:	Scopus-Elsevier
ISSN:	0961-2033
Popis:	The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. Therapeutic approach to this syndrome is discussed.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e01e0942e11c7e5b0ab1c42650a61a4 https://pubmed.ncbi.nlm.nih.gov/9175030 Zobrazit plný text záznamu